This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Bukwang Pharm. Co., Ltd.
Drug Names(s): CTP-010
Description: JM-010 is a new drug combination comprised of undisclosed compounds intended to treat dyskinesia.
In November 2013, Concit Pharma has changed its corporate name to Contera Pharma.
Contera and Bukwang
In November 2014, Contera Pharma announced that Bukwang Pharmaceutical (Seoul, Korea) has acquired 100% of Contera Pharma from its current shareholders. The shareholders received an undisclosed upfront payment and are entitled to future contingent and royalty payments.
Pink Sheet Weekly Trademark Review Jan. 31, 2017
Additional information available to subscribers only: